Induction of Tyrosine Phosphorylation by the Erythropoietin Receptor Correlates with Mitogenesis

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 1991 Oct 1

PMID 1656216

Citations 51

Authors

O Miura

A DAndrea

D Kabat

J N Ihle

Affiliations

Soon will be listed here.

Abstract

A role for tyrosine phosphorylation in the signal-transducing mechanisms of several hematopoietic growth factors has been hypothesized. To extend these observations, we have examined the effects of erythropoietin (Epo) on tyrosine phosphorylation in an Epo-responsive cell that was obtained by transfecting the murine erythropoietin receptor (EpoR) into an interleukin-3 (IL-3)-dependent cell line. By two-dimensional analysis of phosphotyrosine-containing proteins isolated with a monoclonal antibody (1G2) against phosphotyrosine, Epo and IL-3 were found to rapidly induce tyrosine phosphorylation of comparable substrates of 92, 70, and 56 kDa. In addition, Epo uniquely induced phosphorylation of a 72-kDa substrate while IL-3 uniquely induced phosphorylation of a 140-kDa substrate. Immunoprecipitation and mixing experiments indicated that the 72-kDa substrate may represent a small fraction of the EpoR. To explore the significance of tyrosine phosphorylation, we generated two mutants of the EpoR that lacked 108 or 146 amino acids at their carboxyl termini. In addition we constructed an internally deleted mutant that lacked 20 amino acids in a region of sequence homology with the IL-2 receptor beta chain. Although all mutants were expressed at comparable levels and had comparable binding affinities for Epo, only the mutant lacking 108 amino acids at the carboxyl terminus retained significant mitogenic activity or the ability to induce tyrosine phosphorylation.

Citing Articles

Heterogeneity in leukemia cells that escape drug-induced senescence-like state.

Miller D, Kerkhofs K, Abbas-Aghababazadeh F, Madahar S, Minden M, Hebert J Cell Death Dis. 2023; 14(8):503.

PMID: 37543610 PMC: 10404232. DOI: 10.1038/s41419-023-06015-4.

Targeting low-risk myelodysplastic syndrome with novel therapeutic strategies.

Trivedi G, Inoue D, Zhang L Trends Mol Med. 2021; 27(10):990-999.

PMID: 34257007 PMC: 8487963. DOI: 10.1016/j.molmed.2021.06.013.

Heterogeneity of Red Blood Cells: Causes and Consequences.

Bogdanova A, Kaestner L, Simionato G, Wickrema A, Makhro A Front Physiol. 2020; 11:392.

PMID: 32457644 PMC: 7221019. DOI: 10.3389/fphys.2020.00392.

Inhibition of USP9X Downregulates JAK2-V617F and Induces Apoptosis Synergistically with BH3 Mimetics Preferentially in Ruxolitinib-Persistent JAK2-V617F-Positive Leukemic Cells.

Akiyama H, Umezawa Y, Watanabe D, Okada K, Ishida S, Nogami A Cancers (Basel). 2020; 12(2).

PMID: 32050632 PMC: 7072561. DOI: 10.3390/cancers12020406.

Cytokine receptor splice variants in hematologic diseases.

Wang B, Mehta H Cytokine. 2019; 127:154919.

PMID: 31816579 PMC: 6995764. DOI: 10.1016/j.cyto.2019.154919.

References

Horak I, Gress R, Lucas P, Horak E, Waldmann T, Bolen J . T-lymphocyte interleukin 2-dependent tyrosine protein kinase signal transduction involves the activation of p56lck. Proc Natl Acad Sci U S A. 1991; 88(5):1996-2000. PMC: 51153. DOI: 10.1073/pnas.88.5.1996. View

Rohrschneider L, Metcalf D . Induction of macrophage colony-stimulating factor-dependent growth and differentiation after introduction of the murine c-fms gene into FDC-P1 cells. Mol Cell Biol. 1989; 9(11):5081-92. PMC: 363660. DOI: 10.1128/mcb.9.11.5081-5092.1989. View

Kanakura Y, Druker B, Wood K, Mamon H, Okuda K, Roberts T . Granulocyte-macrophage colony-stimulating factor and interleukin-3 induce rapid phosphorylation and activation of the proto-oncogene Raf-1 in a human factor-dependent myeloid cell line. Blood. 1991; 77(2):243-8. View

DAndrea A, Yoshimura A, Youssoufian H, Zon L, Koo J, Lodish H . The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains. Mol Cell Biol. 1991; 11(4):1980-7. PMC: 359883. DOI: 10.1128/mcb.11.4.1980-1987.1991. View

Krantz S . Erythropoietin. Blood. 1991; 77(3):419-34. View

Quelle F, Wojchowski D . Proliferative action of erythropoietin is associated with rapid protein tyrosine phosphorylation in responsive B6SUt.EP cells. J Biol Chem. 1991; 266(1):609-14. View

Enver T, Nakamoto B, Karlinsey J, JOSEPHSON B, Greenberger J, Papayannopoulou T . Erythropoietin changes the globin program of an interleukin 3-dependent multipotential cell line. Proc Natl Acad Sci U S A. 1988; 85(23):9091-5. PMC: 282669. DOI: 10.1073/pnas.85.23.9091. View

PIERCE J, Ruggiero M, Fleming T, Di Fiore P, Greenberger J, Varticovski L . Signal transduction through the EGF receptor transfected in IL-3-dependent hematopoietic cells. Science. 1988; 239(4840):628-31. DOI: 10.1126/science.3257584. View

Shaw A, Amrein K, Hammond C, Stern D, Sefton B, Rose J . The lck tyrosine protein kinase interacts with the cytoplasmic tail of the CD4 glycoprotein through its unique amino-terminal domain. Cell. 1989; 59(4):627-36. DOI: 10.1016/0092-8674(89)90008-1. View

10.

Setchenska M, Arnstein H . Independent activation of adenylate cyclase by erythropoietin and isoprenaline. Mol Cell Endocrinol. 1988; 56(3):199-204. DOI: 10.1016/0303-7207(88)90061-5. View

11.

Setchenska M, Arnstein H . Stimulation of the adenylate cyclase activity of rabbit bone marrow immature erythroblasts by erythropoietin and haemin. Eur J Biochem. 1986; 155(2):363-70. DOI: 10.1111/j.1432-1033.1986.tb09499.x. View

12.

PIERCE J, Di Fiore P, Aaronson S, Potter M, Pumphrey J, Scott A . Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism. Cell. 1985; 41(3):685-93. DOI: 10.1016/s0092-8674(85)80049-0. View

13.

Cook W, Metcalf D, Nicola N, Burgess A, Walker F . Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism. Cell. 1985; 41(3):677-83. DOI: 10.1016/s0092-8674(85)80048-9. View

14.

Miller B, Scaduto Jr R, Tillotson D, Botti J, Cheung J . Erythropoietin stimulates a rise in intracellular free calcium concentration in single early human erythroid precursors. J Clin Invest. 1988; 82(1):309-15. PMC: 303510. DOI: 10.1172/JCI113588. View

15.

Isfort R, Huhn R, Frackelton Jr A, Ihle J . Stimulation of factor-dependent myeloid cell lines with interleukin 3 induces tyrosine phosphorylation of several cellular substrates. J Biol Chem. 1988; 263(35):19203-9. View

16.

Isfort R, Stevens D, May W, Ihle J . Interleukin 3 binds to a 140-kDa phosphotyrosine-containing cell surface protein. Proc Natl Acad Sci U S A. 1988; 85(21):7982-6. PMC: 282337. DOI: 10.1073/pnas.85.21.7982. View

17.

Cleveland J, Dean M, Rosenberg N, Wang J, Rapp U . Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl. Mol Cell Biol. 1989; 9(12):5685-95. PMC: 363740. DOI: 10.1128/mcb.9.12.5685-5695.1989. View

18.

DAndrea A, Lodish H, Wong G . Expression cloning of the murine erythropoietin receptor. Cell. 1989; 57(2):277-85. DOI: 10.1016/0092-8674(89)90965-3. View

19.

Migliaccio G, Migliaccio A, Kreider B, Rovera G, Adamson J . Selection of lineage-restricted cell lines immortalized at different stages of hematopoietic differentiation from the murine cell line 32D. J Cell Biol. 1989; 109(2):833-41. PMC: 2115740. DOI: 10.1083/jcb.109.2.833. View

20.

Miller B, Cheung J, Tillotson D, Hope S, Scaduto Jr R . Erythropoietin stimulates a rise in intracellular-free calcium concentration in single BFU-E derived erythroblasts at specific stages of differentiation. Blood. 1989; 73(5):1188-94. View